Huw M. Nash, COO & CBO at Stoke Therapeutics, Inc. (STOK), sold 10,900 shares at $50.02 ($542K) on 2020-12-01, disclosed to the SEC on 2020-12-03.
Open-market sale of $542k STOK by COO & CBO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $49.19 | 2,719 | $134K | 24.7% |
| 2 | $49.19 | 2,719 | $134K | 24.7% |
| 3 | $50.02 | 2,481 | $124K | 22.9% |
| 4 | $50.02 | 2,481 | $124K | 22.9% |
| 5 | $51.45 | 100 | $5K | 0.9% |
| 6 | $52.72 | 400 |
| $21K |
| 3.9% |
| Total | $49.72 avg | 10,900 | $542K | 100% |
| Filing → |
| STOK | SELL | 2024-04-03 | $1.6M | — | Filing → |
| STOK | SELL | 2024-03-19 | $25K | — | Filing → |
| STOK | SELL | 2022-01-05 | $88K | — | Filing → |